| Literature DB >> 26621252 |
Naomi Folb1, Crick Lund2, Lara R Fairall3, Venessa Timmerman4, Naomi S Levitt5, Krisela Steyn6, Max O Bachmann7.
Abstract
BACKGROUND: Socioeconomic predictors and consequences of depression and its treatment were investigated in 4393 adults with specified non-communicable diseases attending 38 public sector primary care clinics in the Eden and Overberg districts of the Western Cape, South Africa.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26621252 PMCID: PMC4666155 DOI: 10.1186/s12889-015-2509-4
Source DB: PubMed Journal: BMC Public Health ISSN: 1471-2458 Impact factor: 3.295
Participants’ baseline characteristics and associations with baseline CESD-10a scores
| Numberb | Percentb | CESD-10 Mean | CESD-10 SD |
| |
|---|---|---|---|---|---|
| Health indicators | |||||
| Age (years): mean (SD) | 51.6 (13.5) | <0.001 | |||
| Sex | <0.001 | ||||
| •Women | 3193 | 72.7 | 11.2 | 6.4 | |
| •Men | 1199 | 27.3 | 9.7 | 6.2 | |
| Hypertension | <0.001 | ||||
| •No | 1166 | 26.6 | 12.8 | 6.2 | |
| •Yes | 3226 | 73.5 | 10.0 | 6.3 | |
| Diabetes | <0.001 | ||||
| •No | 2551 | 58.1 | 11.8 | 6.4 | |
| •Yes | 1841 | 41.9 | 9.3 | 6.0 | |
| Chronic respiratory Disease | <0.001 | ||||
| •No | 3235 | 73.7 | 10.2 | 6.3 | |
| •Yes | 1157 | 26.3 | 12.2 | 6.4 | |
| CESD-10 score ≥10 | |||||
| •<10 | 1926 | 43.9 | 4.9 | 2.8 | |
| •≥10 | 2466 | 56.2 | 15.3 | 4.3 | |
| Antidepressant, any dose | <0.001 | ||||
| •No | 3545 | 81.3 | 10.2 | 6.1 | |
| •Yes | 818 | 18.8 | 13.2 | 7.0 | |
| Antidepressant, therapeutic dose | <0.001 | ||||
| •No | 3971 | 91.0 | 10.3 | 6.1 | |
| •Yes | 392 | 9.0 | 15.1 | 7.3 | |
| Socioeconomic indicators | |||||
| Language | 0.88 | ||||
| •Afrikaans | 3679 | 83.8 | 10.8 | 6.6 | |
| •Xhosa | 337 | 7.7 | 10.1 | 5.3 | |
| •English | 376 | 8.6 | 10.6 | 5.3 | |
| Highest education | 0.35 | ||||
| •None | 291 | 7.3 | 10.8 | 6.2 | |
| •Primary | 1757 | 44.2 | 11.0 | 6.2 | |
| •Secondary | 1853 | 46.6 | 10.6 | 6.5 | |
| •Tertiary | 75 | 1.9 | 9.9 | 6.4 | |
| Total monthly income (Rand): mean (SD) | 1084 (1254) | <0.001 | |||
| Unemployed | 0.12 | ||||
| •No | 1096 | 25.0 | 10.4 | 6.4 | |
| •Yes | 3282 | 75.0 | 10.9 | 6.4 | |
| Welfare grant | 0.87 | ||||
| •No | 1850 | 42.3 | 10.7 | 6.4 | |
| •Yes | 2528 | 57.7 | 10.8 | 6.4 | |
| Housing density (occupants/rooms): mean (SD) | 1.8 (1.2) | <0.001 |
a CESD-10 10-item Center for Epidemiologic Studies Depression Scale
b Except mean and standard deviation (SD) for continuous variables
c Linear regression models adjusted for cluster sample design
Patients’ baseline characteristics independently associated with CESD-10a score at baseline and with changeb in CESD-10 score: linear regression models
| Outcome | Baseline CESD-10a score | Follow-up CESD-10a scoreb | ||||||
|---|---|---|---|---|---|---|---|---|
| Explanatory variable | Coefficient | 95 % CIa |
| Coefficient | 95 % CIa |
| ||
| Age (per year) | −0.06 | −0.08 | −0.04 | <0.001 | −0.06 | −0.08 | −0.04 | <0.001 |
| Men vs. women | −1.66 | −2.19 | −1.13 | <0.001 | −0.96 | −1.46 | −0.46 | <0.001 |
| Hypertension | −1.93 | −2.60 | −1.27 | <0.001 | −0.53 | −1.07 | 0.00 | 0.052 |
| Diabetes | −1.75 | −2.27 | −1.24 | <0.001 | ||||
| Chronic respiratory disease | 1.21 | 0.51 | 1.91 | <0.001 | 1.06 | 0.58 | 1.54 | <0.001 |
| Highest education | 0.004c | 0.010c | ||||||
| •None (reference) | 1.00 | 1.00 | ||||||
| •Primary | −0.24 | −1.31 | 0.84 | 0.656 | −0.35 | −1.34 | 0.63 | 0.473 |
| •Secondary | −1.19 | −2.33 | −0.05 | 0.042 | −1.48 | −2.50 | −0.47 | 0.005 |
| •Tertiary | −0.93 | −2.70 | 0.83 | 0.291 | −1.64 | −3.03 | −0.25 | 0.022 |
| Language | 0.038c | |||||||
| •Afrikaans (reference) | 1.00 | |||||||
| •Xhosa | 1.90 | 0.42 | 3.37 | 0.013 | ||||
| •English | 1.66 | −0.66 | 3.98 | 0.156 | ||||
| Income (per 1000 Rand per month) | −0.23 | −0.37 | −0.08 | 0.003 | ||||
| Unemployed | 0.53 | −0.08 | 1.15 | 0.086 | ||||
| Welfare grant baseline | 0.54 | −0.02 | 1.10 | 0.060 | 0.66 | 0.19 | 1.13 | 0.007 |
| Baseline CESD-10 scoreb | NA | 0.32 | 0.27 | 0.37 | <0.001 | |||
a CESD-10 10-item Center for Epidemiologic Studies Depression Scale, CI confidence interval, NA not applicable
b Change modelled with analysis of covariance, that is, with baseline value as covariate
c Wald test for all categories of variable
Patient characteristics independently associated with changesa in unemployment and welfare grant income: logistic and linear regression models
| Outcome | Unemployed at follow-upb | Monthly welfare grant income at follow up (Rand)c | ||||||
|---|---|---|---|---|---|---|---|---|
| Explanatory variable | ORd | 95 % CI |
| Coefficient | 95 % CId |
| ||
| CESD-10 score ≥10 at baseline | 1.25 | 1.04 | 1.51 | 0.016 | 55 | 18 | 91 | 0.004 |
| Age (per year) | 1.05 | 1.04 | 1.06 | <0.001 | 9 | 7 | 11 | <0.001 |
| Men vs. women | 0.70 | 0.57 | 0.86 | 0.001 | ||||
| Chronic respiratory disease | 66 | 25 | 108 | 0.003 | ||||
| Diabetes | 27 | 0 | 55 | 0.048 | ||||
| Highest education | <0.001e | 0.017 e | ||||||
| •None (reference) | 1.00 | 0 | ||||||
| •Primary | 0.78 | 0.54 | 1.13 | 0.186 | −38 | −85 | 8 | 0.105 |
| •Secondary | 0.59 | 0.38 | 0.90 | 0.014 | −67 | −115 | −19 | 0.007 |
| •Tertiary | 0.19 | 0.10 | 0.35 | <0.001 | 3 | −212 | 218 | 0.975 |
| Language | 0.052e | <0.001e | ||||||
| •Afrikaans (reference) | 1.00 | 0 | ||||||
| •Xhosa | 0.68 | 0.46 | 1.00 | 0.047 | −158 | −228 | −88 | <0.001 |
| •English | 1.21 | 0.85 | 1.73 | 0.288 | −99 | −162 | −37 | 0.003 |
| Unemployed at baselinea | 13.9 | 10.7 | 18.2 | <0.001 | ||||
| Grant income at baseline (per 1000 Rand per month)a | 602 | 522 | 682 | <0.001 | ||||
a Change modelled with analysis of covariance, that is, with baseline value as covariate
b Logistic regression model
c Linear regression model
d OR odds ratio, CI confidence interval
e Wald test for all categories of variable
Baseline health, socioeconomic and clinic characteristics independently associated with mental health treatments at baseline and at follow-upa, in patients with CESD-10 score of ten or more: logistic regression models
| Outcome | Therapeutic dose of antidepressant drug at baseline | Therapeutic dose of antidepressant drug at follow-upa | Psychiatric referral between baseline and follow-up | Counselling between baseline and follow-up | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Explanatory variable | ORb | 95 % CIb |
| OR | 95 % CI |
| OR | 95 % CI |
| OR | 95 % CI |
| ||||
| Patient characteristics | ||||||||||||||||
| Age (per year) | 0.97 | 0.95 | 0.98 | <0.001 | 0.97 | 0.96 | 0.98 | <0.001 | ||||||||
| Men vs. women | 0.31 | 0.19 | 0.49 | <0.001 | 0.34 | 0.22 | 0.53 | <0.001 | 0.67 | 0.43 | 1.03 | 0.069 | ||||
| Hypertension | 0.75 | 0.60 | 0.95 | 0.016 | ||||||||||||
| Diabetes | 0.72 | 0.49 | 1.06 | 0.094 | 0.71 | 0.48 | 1.04 | 0.079 | ||||||||
| Highest education | 0.002c | 0.006c | 0.022c | |||||||||||||
| •None (reference) | 1.00 | 1.00 | 1.00 | |||||||||||||
| •Primary | 1.36 | 0.75 | 2.47 | 0.314 | 1.11 | 0.51 | 2.38 | 0.797 | 0.85 | 0.51 | 1.41 | 0.529 | ||||
| •Secondary | 1.98 | 1.10 | 3.55 | 0.022 | 1.37 | 0.62 | 2.99 | 0.435 | 0.81 | 0.49 | 1.33 | 0.401 | ||||
| •Tertiary | 2.06 | 0.91 | 4.66 | 0.082 | 4.00 | 1.57 | 10.15 | 0.004 | 1.99 | 1.08 | 3.68 | 0.028 | ||||
| Language | <0.001c | 0.003c | ||||||||||||||
| •Afrikaans (reference) | 1.00 | 1.00 | ||||||||||||||
| •Xhosa | 0.23 | 0.15 | 0.35 | <0.001 | 0.16 | 0.05 | 0.45 | 0.001 | ||||||||
| •English | 0.85 | 0.54 | 1.35 | 0.488 | 1.10 | 0.64 | 1.90 | 0.732 | ||||||||
| Income (per 1000 rand per month) | 1.31 | 1.18 | 1.44 | <0.001 | 1.21 | 1.03 | 1.43 | 0.023 | 1.19 | 1.05 | 1.34 | 0.005 | ||||
| Unemployed | 2.01 | 1.32 | 3.09 | 0.001 | ||||||||||||
| Welfare grant | 1.35 | 0.96 | 1.90 | 0.082 | 1.36 | 1.13 | 1.64 | 0.001 | ||||||||
| Baseline CESD-10 score (per unit) | 1.15 | 1.12 | 1.19 | <0.001 | 1.06 | 1.00 | 1.11 | 0.033 | 1.11 | 1.06 | 1.15 | <0.001 | 1.06 | 1.03 | 1.10 | <0.001 |
| Therapeutic dose of antidepressant at baselinea | NAb | 136.90 | 77.25 | 242.61 | <0.001 | NA | NA | |||||||||
| Clinic characteristics | ||||||||||||||||
| Pharmacist in clinic | 1.86 | 1.25 | 2.78 | 0.002 | 1.58 | 0.99 | 2.51 | 0.053 | ||||||||
| Drug supply available away from clinic | 1.67 | 1.11 | 2.50 | 0.013 | 1.59 | 0.95 | 2.66 | 0.078 | ||||||||
| Psychiatric nurse at clinic | 0.32 | 0.13 | 0.80 | 0.015 | ||||||||||||
| Doctor at clinic every day | 1.48 | 0.95 | 2.30 | 0.084 | ||||||||||||
| Clinic location | 0.038c | |||||||||||||||
| •Urban (reference) | 1.00 | |||||||||||||||
| •Peri-urban | 1.17 | 0.66 | 2.08 | 0.599 | ||||||||||||
| •Rural | 2.60 | 1.18 | 5.76 | 0.018 | ||||||||||||
| Clinic patients per year/10,000 | 1.04 | 0.99 | 1.10 | 0.081 | ||||||||||||
| Clinic patients per nurse per year/1000 | 0.93 | 0.88 | 0.99 | 0.022 | ||||||||||||
| Intervention vs. control clinic | 1.39 | 0.97 | 1.98 | 0.073 | 0.57 | 0.35 | 0.91 | 0.020 | 0.54 | 0.33 | 0.88 | 0.013 | ||||
a Change modelled with analysis of covariance, that is, with baseline value as covariate
b OR odds ratio, CI confidence interval, NA not applicable
c Wald test for all categories of variable